Origin Life Sciences, Plasma generated Nitric Oxide (N#O) technology has been selected for a presentation at MHSRS. The abstract is titled "NO: a novel, pathogenic-agnostic therapy for treatment-resistant wound infections in the warfighter"
globenewswire.com/news-relea…
14
Gene Ollinger, at The Life Sciences Division talks in detail about the risks and current situation regarding H5N1 (bird flu). An increasing concern with pandemic potential. Is disease X, H5N1?
youtu.be/p5B2Hxmbg3U?feature…
50
Excellent news from the MHRA, and another major milestone for UK patients.
#mhra
gov.uk/government/news/mhra-…
49
The TLSD team's research indicates the significant potential for IHAT and the company, subject to having sufficient financial resources to commercialise IHAT to its full potential.
accesswire.com/793386/nemysi…
53
How AlphaFold and other AI tools could help us prepare for the next pandemic nature.com/articles/d41586-0…
43
UK Government and MHRA have launched another positive programme (IDAP), this time, for medical devices, to expedite their route to market and adoption. The UK is becoming a centre of innovation globally.
gov.uk/government/news/uk-pa…
29
This is very welcome news when it is announced. Academics and biotechs in the UK need to be part of the Horizon Programme...
BBC News - UK expected to re-join Horizon science scheme
bbc.co.uk/news/uk-politics-6…
27
President Biden announced the first 10 drugs for price controls, and he’s exaggerating the benefits while ignoring the larger damage. wsj.com/articles/drug-price-…
15
The UK's Chancellor of the Exchequer is revealing a major boost for financing of the UK Life Sciences Sector in a speech tonight...
"leading pensions firms to put 5% of their investments into early....life sciences, biotech ...by 2030."
bbc.co.uk/news/business-6615…
31
Very imp devlt as it has been agreed that Pension schemes will put 5% of their investments into early-stage businesses in the fintech, life sciences, biotech and clean technology sectors by 2030. Good to see real money working towards developing the future bbc.com/news/business-661526…
30
Only 28% of drugs big Pharma get to market are internally developed...Innovation is externally sourced...
28
TLSD attended Swiss-UK Innovation Forum today in Basel. Proud to provide an update on the Three Cell& Gene Therapy conferences in Switzerland (2022-2023).
#biotech #Switzerland #UK
23
The Life Sciences Division was proud to be one of the main sponsors of The inaugural King Charles III coronation and birthday party at the Ambassador's residence yesterday evening.
linkedin.com/posts/marie-gow…
28
Alia Minhas, CEO of TLSD, is chairing a funding panel at the Swiss Innovation Forum to be held in Basel on 29 June.
nitter.cf/UKEmbassyBerne/status/…
❗️Panel announcement❗️
🇬🇧-🇨🇭 Innovation Forum: eventbrite.co.uk/e/uk-swiss-…
We are delighted to announce our Investor Panel, moderated by Alia Minhas.
The Panel will discuss their investment priorities in Life Sciences & how start-ups from other countries can engage with them.
2
37
Bull market rotation? Normally large US cap leads... and here US small cap is leading! Biotech small cap indices are doing better than we have seen in a while.
@Financialtimes @biotech @markets @investmentnews
The Life Sciences Division retweeted
PROs = Patient Reported Outcomes.
They allow us to think about the needs of people living with #HIV beyond just medicine.
The funding will be used to accelerate routes for bringing innovative medical products developed in the UK onto the market, as well as those made and approved by other trusted regulatory partners globally.
gov.uk/government/news/mhra-…
31







